153549-78-1

Basic information

• Product Name: (D-TRP32)-NEUROPEPTIDE Y (HUMAN, RAT)
• Synonyms: H-TYR-PRO-SER-LYS-PRO-ASP-ASN-PRO-GLY-GLU-ASP-ALA-PRO-ALA-GLU-ASP-MET-ALA-ARG-TYR-TYR-SER-ALA-LEU-ARG-HIS-TYR-ILE-ASN-LEU-ILE-D-TRP-ARG-GLN-ARG-TYR-NH2;[DTRP32]NEUROPEPTIDE Y (1-36), HUMAN;(D-TRP32)-NEUROPEPTIDE Y (HUMAN, RAT);(D-TRP32)-NEUROPEPTIDE Y (PORCINE);[DTRP32] NPY (1-36), HUMAN;(D-TRP32)-NPY (HUMAN, RAT);(D-TRP32)-NPY (PORCINE);neuropeptide Y, Trp(32)-
• CAS NO: 153549-78-1
• Molecular Formula: C29H34N4O10S
• Molecular Weight: 630.66606
• Mol File: 153549-78-1.mol
• Article Data: 0

Chemical Properties

• Appearance: /
• CAS DataBase Reference: (D-TRP32)-NEUROPEPTIDE Y (HUMAN, RAT)(CAS DataBase Reference)
• NIST Chemistry Reference: (D-TRP32)-NEUROPEPTIDE Y (HUMAN, RAT)(153549-78-1)
• EPA Substance Registry System: (D-TRP32)-NEUROPEPTIDE Y (HUMAN, RAT)(153549-78-1)

Safety Data

• Hazardous Substances Data: 153549-78-1(Hazardous Substances Data)

Usage

Description

(D-TRP32)-NEUROPEPTIDE Y (HUMAN, RAT) is a modified peptide hormone derived from Neuropeptide Y (NPY), a key regulator of physiological processes such as food intake, energy balance, and cardiovascular function. The modification involves the substitution of the amino acid tryptophan with its D-enantiomer at position 32, which can alter the peptide's biological activity and receptor selectivity. This modified form of NPY has been studied in both human and rat models and may have potential therapeutic implications for the treatment of various metabolic and cardiovascular disorders.

Uses

Used in Pharmaceutical Industry:
(D-TRP32)-NEUROPEPTIDE Y (HUMAN, RAT) is used as a therapeutic agent for the treatment of obesity, diabetes, and cardiovascular diseases. Its unique modification allows for altered biological activity and receptor selectivity, which may provide novel treatment options for these conditions.
Used in Research Applications:
(D-TRP32)-NEUROPEPTIDE Y (HUMAN, RAT) is used as a research tool for studying the pathophysiology of metabolic and cardiovascular disorders. Its unique properties allow researchers to investigate the role of NPY and its receptors in these conditions, potentially leading to the discovery of new therapeutic targets and strategies.
Used in Drug Development:
(D-TRP32)-NEUROPEPTIDE Y (HUMAN, RAT) is used in the development of new drugs targeting NPY receptors. Its modified structure may offer advantages over native NPY, such as improved receptor selectivity and reduced side effects, making it a promising candidate for the development of novel therapeutic agents.
Used in Diagnostic Applications:
(D-TRP32)-NEUROPEPTIDE Y (HUMAN, RAT) can be used as a diagnostic marker for metabolic and cardiovascular disorders. Its unique properties and potential association with these conditions make it a valuable tool for early detection and monitoring of disease progression.